Skip to main content

CA Jury Awards $9M To Injured Man In DUI Suit

CA Jury Awards $9M To Injured Man In DUI Suit

CA Jury Awards $9M To Injured Man In DUI Suit

Introduction

A man who suffered serious injuries in a traffic collision in Lancaster in 2017 caused by a drunk driver has received a settlement of about $9 million.

The plaintiff's lawsuit against a drunk driver resulted in a $8.9 million jury verdict in the Los Angeles Superior Court. The defendant, who did not show up during the trial, was eventually represented by MetLife insurance in the matter.

In the case, it is claimed that on January 13, 2017, the plaintiff and his wife were returning from dinner on Avenue N when the drunk defendant sped into oncoming traffic and collided head-on with their vehicle, leaving the plaintiff with serious fractures and a traumatic brain damage. According to the lawsuit, the defendant's breathalyzer result during a field sobriety test was.101, far higher than the.08 DUI threshold.

The primary plaintiff's attorney stated, "You just had to look at our client to realise that he had a long and challenging road to rehabilitation ahead of him. However, MetLife would claim that his wounds weren't serious and that he could resume living a regular life.

The plaintiff was partially to blame for the collision, according to MetLife experts retained for the case.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.